Navigation Links
HIV Collaborative Fund Receives Gates Foundation Grant for AIDS Treatment and Prevention Advocacy
Date:12/5/2007

Global Network of HIV Positive Activists Awarded Three-Year $5.2 Million Grant

SAN FRANCISCO, Dec. 5 /PRNewswire-USNewswire/ -- The HIV Collaborative Fund, a partnership of the International Treatment Preparedness Coalition and Tides, announced today that it has received a three-year grant for $5.2 million from the Bill & Melinda Gates Foundation to support community-based organizations in sub-Saharan Africa engaged in advocacy and educational activities to increase access to HIV treatment and prevention services.

The HIV Collaborative Fund uses a unique funding mechanism in which all funding decisions are guided by the members of the International Treatment Preparedness Coalition (ITPC), a global coalition of people living with AIDS and their advocates, to strengthen access to comprehensive and equitable treatment, care and prevention services. The HIV Collaborative Fund is a project of Tides. Fiscal sponsorship is provided by Tides Center and grants are administered through Tides Foundation.

"People living with HIV and grassroots organizations have a unique and important role to play in advocating for HIV services, fighting stigma, partnering in the delivery of lifesaving prevention and care services, and strengthening governmental leadership on AIDS," said Joe Cerrell, Director of Global Health Policy and Advocacy at the Gates Foundation.

"Support from the Gates Foundation will allow ITPC to strengthen its network capacity across sub-Saharan Africa and create models for service delivery, advocacy and communications that we will apply around the world," said Greg Gray, ITPC's International Coordinator.

ITPC members around the world advocate for increased access to HIV treatment, evidence-based prevention services, and the human rights of people living with AIDS. The Coalition's semi-annual Missing the Target reports provide an on-the-ground assessment of the impact of HIV treatment programs in countries around
'/>"/>

SOURCE HIV Collaborative Fund
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Health care incentive model offers collaborative approach
2. Sanofi-aventis US Chairman Tim Rothwell Addresses CMSAs Collaborative Practice Summit
3. Collaborative Drug Discovery, Inc. and St. Jude Childrens Research Hospital Make Malaria Research Data Available to Speed Drug Development
4. Free Access to Literature Data on Chagas Disease Offered Online: Collaborative Drug Discovery, Inc. provides Neglected Disease researchers with archive mine and collaborate access to small molecule bioactivity SAR data on parasitic disease
5. First-Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions
6. AIDS Healthcare Foundation and NCHADS to Open the 7th collaborative ART Center in Pea Reang
7. Digital Lightbox(C) Unlocks New Possibilities in Collaborative Patient Treatment
8. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
9. DaVita Receives Civil Complaint
10. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:eDiets.com(R) Announces Q3 2008 Results 2Health News:eDiets.com(R) Announces Q3 2008 Results 3Health News:eDiets.com(R) Announces Q3 2008 Results 4Health News:eDiets.com(R) Announces Q3 2008 Results 5Health News:eDiets.com(R) Announces Q3 2008 Results 6Health News:eDiets.com(R) Announces Q3 2008 Results 7Health News:Pelvic Inflammation Puts Girls at Risk for Repeat STIs 2Health News:Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer 2Health News:Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer 3Health News:Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer 4Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 2Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 3Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 4Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 5Health News:Leading Scientists From Around the World Headed to Kansas for Symposium on Combating Deadly Infectious Diseases 2Health News: FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause 2Health News: FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause 3Health News: FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause 4
Breaking Medicine Technology:Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8Preventing toxic shock syndrome and other severe diseases 53247 1Got zinc 3F New zinc research suggests novel therapeutic targets 9433 1Got zinc 3F New zinc research suggests novel therapeutic targets 9433 2Recovery act funded research projects aid communities across the country 9428 1